Viewing nowCombinationEmpaanduo Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202302305 · Approved 2023.07.31 · Insurance code 657309110
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medicine is used in conjunction with diet and exercise to improve blood sugar control in adult patients with type 2 diabetes. It is particularly effective for patients whose blood sugar is not adequately controlled, and caution is required when used in patients with cardiovascular disease. This medicine aids in blood sugar management and is utilized for the treatment of type 2 diabetes.
The recommended dosage of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when starting this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dosage adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medicine includes two components, empagliflozin and metformin hydrochloride, that help control blood sugar. It is important to be cautious as this medicine may cause a rare but serious side effect known as lactic acidosis. Lactic acidosis is a condition where lactic acid builds up excessively in the body, and symptoms may include fatigue, muscle pain, difficulty in breathing, and abdominal pain. If any of these symptoms occur, consult a doctor immediately. Moreover, when taken in conjunction with other diabetes medications such as insulin or sulfonylureas, the risk of hypoglycemic symptoms may increase, so blood sugar levels should be monitored frequently and medication doses adjusted in consultation with a doctor if necessary. Patients with decreased kidney function, acute infections, dehydration, heart problems, or severe liver disease should not take this medicine as it may increase the risk of side effects due to drug accumulation in such conditions. During the course of taking this medicine, regular monitoring of kidney function is required, and special care is necessary for elderly patients or those with slightly reduced kidney function. If undergoing tests or surgeries involving iodine contrast agents, this medicine should be discontinued 48 hours prior to the procedure and can be resumed only after kidney function has normalized. This medicine may cause urinary tract infections or genital infections, so prompt treatment should be sought if related symptoms occur. Due to the metformin component, there may be a decrease in vitamin B12 levels, so it is advisable to monitor vitamin B12 levels during prolonged use. Pregnant women or women who may become pregnant, as well as those who are breastfeeding, should not take this medicine, and if currently taking it, they should consult a doctor. Furthermore, alcohol can increase the risk of side effects from this medicine, so it is crucial to avoid excessive drinking during treatment. This medicine is not recommended for children under 18 years of age, and special caution is needed for elderly patients over 75 years due to changes in body fluid status and decreased kidney function. In cases of overdose, there is a particular risk of lactic acidosis, so immediate medical attention should be sought if suspected. Finally, it is safest to store this medicine out of reach of children, and to keep it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the medication’s effectiveness is preserved for a longer time.
Dark brownish to purplish, oval, biconvex film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.